Related Experiment Video
Updated: Aug 27, 2025

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era
Jasleen Saini1, Pritpal Kaur1, Naveen Malik2
1Department of Biotechnology, Sri Guru Granth Sahib World University, Fatehgarh Sahib, Punjab, India.
Abstract:
COVID-19 (Coronavirus Disease 2019), a life-threatening viral infection, is caused by a highly pathogenic virus named SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). Currently, no treatment is available for COVID-19; hence there is an urgent need to find effective therapeutic drugs to combat COVID-19 pandemic. Considering the fact that the world is facing a major issue of antimicrobial drug resistance, naturally occurring compounds have the potential to achieve this goal. Antimicrobial peptides (AMPs) are naturally occurring antimicrobial agents which are effective against a wide variety of microbial infections. Therefore, the use of AMPs is an attractive therapeutic strategy for the treatment of SARS-CoV-2 infection. This review sheds light on the potential of antimicrobial peptides as antiviral agents followed by a comprehensive description of effective antiviral peptides derived from various natural sources found to be effective against SARS-CoV and other respiratory viruses. It also highlights the mechanisms of action of antiviral peptides with special emphasis on their effectiveness against SARS-CoV-2 infection.
Insights
Antimicrobial peptides (AMPs) show promise in treating COVID-19. These natural compounds are effective against SARS-CoV-2 and other respiratory viruses, offering a potential therapeutic strategy.
Area of Science:
- Biochemistry
- Virology
- Pharmacology
Background:
- COVID-19, caused by SARS-CoV-2, is a severe global health threat with no current treatments.
- Antimicrobial drug resistance necessitates novel therapeutic approaches.
- Naturally occurring compounds, like antimicrobial peptides (AMPs), offer potential solutions.
Purpose of the Study:
- To explore the antiviral potential of antimicrobial peptides (AMPs) against SARS-CoV-2.
- To review AMPs derived from natural sources effective against respiratory viruses.
- To elucidate the mechanisms of action of antiviral peptides against SARS-CoV-2.
Main Methods:
- Literature review of existing studies on AMPs and their antiviral properties.
- Analysis of natural sources for effective antiviral peptides.
- Examination of the mechanisms of action of AMPs against viral infections.
Main Results:
- Antimicrobial peptides (AMPs) demonstrate significant potential as antiviral agents.
- Several AMPs derived from natural sources show efficacy against SARS-CoV and other respiratory viruses.
- AMPs exhibit diverse mechanisms of action against viral pathogens.
Conclusions:
- Antimicrobial peptides (AMPs) represent a promising therapeutic strategy for COVID-19 treatment.
- Further research into AMPs could lead to novel drugs to combat SARS-CoV-2.
- The natural origin and broad-spectrum activity of AMPs make them attractive candidates for antiviral drug development.
More Related Videos
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antimicrobial Effectiveness
Development of Antibiotic Resistance
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Gene Regulation in Microbial Communities: Quorum Sensing
Biological Methods for Microbial Control

